A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin-Reference-Cited by-同舟云学术

A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin

Published:2024-03-25 Issue:1 Volume:147 Page:
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Casselini Carolina M.,Parson Henri K.,Frizzi Katie E.,Marquez Alex,Smith Darrell R.,Guernsey Lucie,Nemmani Rakesh,Tayarani Alireza,Jolivalt Corinne G.^ORCID,Weaver Jessica,Fernyhough Paul,Vinik Aaron I.,Calcutt Nigel A.

Funder

national Institute of health

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00401-024-02710-4.pdf

Reference56 articles.

1. Anand P, Privitera R, Donatien P, Fadavi H, Tesfaye S, Bravis V et al (2022) Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration. Front Neurol 13:998904. https://doi.org/10.3389/fneur.2022.998904

2. Appell RA, Chancellor MB, Zobrist RH, Thomas H, Sanders SW (2003) Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects. Mayo Clin Proc 78:696–702. https://doi.org/10.4065/78.6.696

3. Azmi S, Jeziorska M, Ferdousi M, Petropoulos IN, Ponirakis G, Marshall A et al (2019) Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation. Diabetologia 62:1478–1487. https://doi.org/10.1007/s00125-019-4897-y

4. Bastyr EJ 3rd, Price KL, Bril V, Group MS (2005) Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 27:1278–1294. https://doi.org/10.1016/j.clinthera.2005.08.002

5. Boyd A, Casselini C, Vinik E, Vinik A (2011) Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate. J Diabetes Sci Technol 5:714–722. https://doi.org/10.1177/193229681100500326